Title: Pharmaceutical price regulation
First published: 1997
Description: Increasing global regulation of drug prices and expenditures already affects the efficiency of pharmaceutical R&D and of health care delivery, with important implications for patient care now and in the future. The author examines the effect of existing foreign regulation - price controls, rate-of-return regulations, and industrial policies - on U.S. and other multinational producers of innovative drugs.

She explores the growing threat to global revenues from the regulatory use of international price comparisons and the increasing threat from parallel trade.
Subjects: Drugs, Prices, Pharmaceutical industry, Pharmaceutical policy, Pharmaceutical Economics, Drogues, Gesundheitspolitik, Arzneimittelmarkt, Geneesmiddelen, Cost Control, Farmaceutische industrie, Physical fitness, Politique gouvernementale, Preisregelung, Public Policy, Politique pharmaceutique, Medicaments, Drug Costs, Prix, Arzneimittelpreis, Industrie pharmaceutique, Industrie pharmacautique, Prijsbeleid, Drugs, prices
Places: United States
LC classification: HD9666.4 .D36 1997